Arsenal and Linden recap BioIVT

Arsenal Capital Partners and Linden Capital have recapitalized BioIVT, a Westbury, New York-based provider of biological specimens.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this